Affiliation:
1. Laboratoire de Bactériologie, Université Victor Segalen Bordeaux 2, 33076 Bordeaux Cedex, France
Abstract
ABSTRACT
The activities of garenoxacin, gatifloxacin, and gemifloxacin were compared with those of four fluoroquinolones against human mycoplasmas and ureaplasmas, including fluoroquinolone-resistant genetically characterized strains. Garenoxacin exhibited the highest activity, followed by gemifloxacin, moxifloxacin, and gatifloxacin. The minimal bactericidal activities of these three compounds were lower than those of the four fluoroquinolones.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference16 articles.
1. In Vitro Activity of BAY 12-8039, a New Fluoroquinolone, against Mycoplasmas
2. Alterations in Topoisomerase IV and DNA Gyrase in Quinolone-Resistant Mutants of
Mycoplasma hominis
Obtained In Vitro
3. DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of
Ureaplasma
spp. and
Mycoplasma hominis
Resistant to Fluoroquinolones
4. Mutations in the
gyrA
,
parC
, and
parE
Genes Associated with Fluoroquinolone Resistance in Clinical Isolates of
Mycoplasma hominis
5. Duffy, L. B., D. Crabb, K. Searcey, and M. C. Kempf. 2000. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp. J. Antimicrob. Chemother.45:29-33.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献